Logo image
Mice Expressing A53T/A30P Mutant Alpha-Synuclein in Dopamine Neurons Do Not Display Behavioral Deficits
Journal article   Open access   Peer reviewed

Mice Expressing A53T/A30P Mutant Alpha-Synuclein in Dopamine Neurons Do Not Display Behavioral Deficits

Cameron Keomanivong, Josephine Schamp, Ervina Tabakovic, Ramasamy Thangavel, Georgina Aldridge, Andrew A Pieper and Nandakumar S Narayanan
eNeuro, Vol.11(2), pp.1-6
02/2024
DOI: 10.1523/ENEURO.0170-23.2023
PMCID: PMC10866330
PMID: 38351057
url
https://doi.org/10.1523/ENEURO.0170-23.2023View
Published (Version of record) Open Access

Abstract

Alpha-synuclein has been implicated in neurodegenerative diseases such as Parkinson's disease and dementia with Lewy bodies, with A53T and A30P mutations shown to be disease causing. It has been reported that hemizygous transgenic mice with tyrosine hydroxylase promotor-driven expression of A53T/A30P mutant alpha-synuclein in dopamine neurons provide a useful preclinical model of these conditions by virtue of developing behavioral deficits. Here, we report a lack of replication of this finding. Despite detecting robust overexpression of A53T/A30P mutant alpha-synuclein in dopamine neurons, we did not observe decreased tyrosine hydroxylase immunofluorescence or behavioral deficits in these mice. Our results demonstrate that preclinical models of synucleinopathy need careful validation in the field.
alpha-Synuclein - genetics alpha-Synuclein - metabolism Animals Disease Models, Animal Dopaminergic Neurons - metabolism Mice Mice, Transgenic Parkinson Disease - genetics Tyrosine 3-Monooxygenase - genetics

Details

Metrics

Logo image